Powerlifting Athlete Suspended for the Presence and Use of SARM LGD-4033

Ottawa – February 14, 2022 – The Canadian Centre for Ethics in Sport (CCES) announced today that Darren Gagnon-Maltais, a powerlifting athlete, received a sanction of four years for an anti-doping rule violation. The athlete’s urine sample, collected during an out-of-competition doping control on August 1, 2021, revealed the presence and use of SARM LGD-4033, a prohibited anabolic agent.

In response to the CCES’s notification of the adverse analytical finding, Mr. Gagnon-Maltais requested a hearing to determine the violation and whether the proposed sanction period should be eliminated or reduced. On January 24, 2022, Arbitrator Janie Soublière confirmed the violation and imposed a sanction of four years of ineligibility from sport. As the athlete accepted a voluntary provisional suspension on September 12, 2021, the sanction will conclude on September 11, 2025.

During the sanction period, the athlete, who resides in Donnacona, Quebec, is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates.

The full decision can be found at www.crdsc-sdrcc.ca.

About the CCES

The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities, and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.

-- 30 --

For further information, please contact:

Megan Cumming
Corporate Communications Manager
+1 613-521-3340 x3233
[email protected]

See Also...

Canadian Anti-Doping Program

The 2021 Canadian Anti-Doping Program came into effect on January 1, 2021, ensuring the program’s ongoing compliance with the World Anti-Doping Code.